(Q44855302)

6 December 2017

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer (English)

1 reference

6 December 2017

1 reference

1 reference

2

1 reference

6 December 2017

Christopher S Saigal

1

1 reference

6 December 2017

Tracey L Krupski

3

1 reference

6 December 2017

Janet Hanley

4

1 reference

6 December 2017

Matthias Schonlau

5

1 reference

6 December 2017

Mark S Litwin

6

1 reference

6 December 2017

Urologic Diseases in America Project

7

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

6 December 2017

1 reference

6 December 2017

110

1 reference

6 December 2017

7

1 reference

6 December 2017

1493-1500

1 reference

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

6 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

National practice patterns and time trends in androgen ablation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Cause of death in men diagnosed with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmö Preventive Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Development of a comorbidity index using physician claims data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

The relationship of natural androgens to coronary heart disease in males: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

The third analysis of the bicalutamide Early Prostate Cancer programme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Insulin resistance, body fat distribution, and sex hormones in men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Plasminogen activator inhibitor in plasma is related to testosterone in men

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Bio-available testosterone levels fall acutely following myocardial infarction in men: association with fibrinolytic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Mortality by Hispanic status in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Ischemic heart disease mortality in Hispanics, American Indians, and non-Hispanic whites in New Mexico, 1958-1982

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22933

7 January 2021

Identifiers

DOI

10.1002/CNCR.22933

1 reference

6 December 2017

1 reference